{"id":2111,"date":"2024-03-15T15:51:05","date_gmt":"2024-03-15T14:51:05","guid":{"rendered":"https:\/\/tafalgie.fr\/participer-au-programme-ipoready-2024\/"},"modified":"2024-07-11T14:27:29","modified_gmt":"2024-07-11T12:27:29","slug":"participer-au-programme-ipoready-2024","status":"publish","type":"post","link":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/","title":{"rendered":"Participation au programme \u00ab\u00a0IPOready 2024\u00a0\u00bb"},"content":{"rendered":"\n<div class=\"wp-block-cover alignfull is-light\" style=\"min-height:130px;aspect-ratio:unset;\"><span aria-hidden=\"true\" class=\"wp-block-cover__background has-background-dim-100 has-background-dim\" style=\"background-color:#ffffff\"><\/span><div class=\"wp-block-cover__inner-container is-layout-flow wp-block-cover-is-layout-flow\">\n<p class=\"has-text-align-center has-large-font-size\"><\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading text-gradient from-dark-to-light_blue\" style=\"font-style:normal;font-weight:600\"><strong><u>Tafalgie Therapeutics participera au programme pre-IPO \u2018IPOready\u2019 2024 organis\u00e9 par Euronext pour la 9\u00e8me ann\u00e9e cons\u00e9cutive<\/u><\/strong><\/h2>\n\n\n\n<div style=\"height:28px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<figure class=\"wp-block-image alignwide size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg\" alt=\"\" class=\"wp-image-1814\" srcset=\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg 1024w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-300x200.jpeg 300w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-768x512.jpeg 768w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1536x1024.jpeg 1536w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-2048x1365.jpeg 2048w, https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-700x467.jpeg 700w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<p>Tafalgie Therapeutics, une soci\u00e9t\u00e9 de recherche biopharmaceutique sp\u00e9cialis\u00e9e dans la recherche et l\u2019innovation des traitements pour la pr\u00e9vention et le soulagement des douleurs aigu\u00ebs et chroniques (inflammatoires, postop\u00e9ratoires, neuropathiques) sans effets ind\u00e9sirables, est fi\u00e8re d\u2019annoncer qu\u2019elle a \u00e9t\u00e9 s\u00e9lectionn\u00e9e pour participer au programme \u2018iPOready\u2019 2024 qui a pour objectif de soutenir des soci\u00e9t\u00e9s europ\u00e9ennes \u00e0 croissance rapide avec le potentiel d\u2019\u00eatre cot\u00e9es sur Euronext.<\/p>\n\n\n\n<p>Tafalgie Therapeutics et son \u00e9quipe de gestion auront donc acc\u00e8s \u00e0 tous les outils et toutes les informations n\u00e9cessaires \u00e0 l\u2019acc\u00e9l\u00e9ration du d\u00e9veloppement en vue de l\u2019\u00e9tablissement potentiel d\u2019un processus IP dans les ann\u00e9es \u00e0 venir.<\/p>\n\n\n\n<p><strong>Tafalgie Therapeutics participera \u00e0 ce programme au c\u00f4t\u00e9, cette ann\u00e9e, de plus de cent soixante soci\u00e9t\u00e9s de quinze pays europ\u00e9ens. Ces chiffres attestent du dynamisme d\u2019un pool d\u2019ambitieuses soci\u00e9t\u00e9s \u00e0 croissance rapide, ayant pour objectif d\u2019\u00eatre cot\u00e9es \u00e0 l\u2019\u00e9chelle europ\u00e9enne, et de la pertinence du choix d\u2019Euronext comme principale plateforme de cotation en Europe.<\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><a id=\"_msocom_1\"><\/a><\/p>\n\n\n\n<p><a id=\"_msocom_1\"><\/a><\/p>\n\n\n\n<div style=\"height:71px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Tafalgie Therapeutics participera au programme pre-IPO \u2018IPOready\u2019 2024 organis\u00e9 par Euronext pour la 9\u00e8me ann\u00e9e cons\u00e9cutive Tafalgie Therapeutics, une soci\u00e9t\u00e9 de recherche biopharmaceutique sp\u00e9cialis\u00e9e dans la recherche et l\u2019innovation des traitements pour la pr\u00e9vention et le soulagement des douleurs aigu\u00ebs et chroniques (inflammatoires, postop\u00e9ratoires, neuropathiques) sans effets ind\u00e9sirables, est fi\u00e8re d\u2019annoncer qu\u2019elle a \u00e9t\u00e9 s\u00e9lectionn\u00e9e [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[55],"tags":[26,68,64,65,67,69],"class_list":["post-2111","post","type-post","status-publish","format-standard","hentry","category-evenements","tag-euronext","tag-la-participation","tag-pret-pour-lipo","tag-programme","tag-programme-de-pre-introduction-en-bourse","tag-societe-europeenne"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Participation au programme &quot;IPOready 2024&quot; - Tafalgie Therapeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Participation au programme &quot;IPOready 2024&quot; - Tafalgie Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Tafalgie Therapeutics participera au programme pre-IPO \u2018IPOready\u2019 2024 organis\u00e9 par Euronext pour la 9\u00e8me ann\u00e9e cons\u00e9cutive Tafalgie Therapeutics, une soci\u00e9t\u00e9 de recherche biopharmaceutique sp\u00e9cialis\u00e9e dans la recherche et l\u2019innovation des traitements pour la pr\u00e9vention et le soulagement des douleurs aigu\u00ebs et chroniques (inflammatoires, postop\u00e9ratoires, neuropathiques) sans effets ind\u00e9sirables, est fi\u00e8re d\u2019annoncer qu\u2019elle a \u00e9t\u00e9 s\u00e9lectionn\u00e9e [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Tafalgie Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-15T14:51:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-11T12:27:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg\" \/>\n<meta name=\"author\" content=\"Tafalgie_client_23\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tafalgie_client_23\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/\"},\"author\":{\"name\":\"Tafalgie_client_23\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56\"},\"headline\":\"Participation au programme \u00ab\u00a0IPOready 2024\u00a0\u00bb\",\"datePublished\":\"2024-03-15T14:51:05+00:00\",\"dateModified\":\"2024-07-11T12:27:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/\"},\"wordCount\":208,\"publisher\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg\",\"keywords\":[\"Euronext\",\"La participation\",\"Pr\u00eat pour l'IPO\",\"Programme\",\"Programme de pr\u00e9-introduction en bourse\",\"Soci\u00e9t\u00e9 europ\u00e9enne\"],\"articleSection\":[\"Ev\u00e9nements\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/\",\"url\":\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/\",\"name\":\"Participation au programme \\\"IPOready 2024\\\" - Tafalgie Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg\",\"datePublished\":\"2024-03-15T14:51:05+00:00\",\"dateModified\":\"2024-07-11T12:27:29+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#primaryimage\",\"url\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg\",\"contentUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#website\",\"url\":\"https:\/\/tafalgie.fr\/fr\/\",\"name\":\"Tafalgie Therapeutics\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tafalgie.fr\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#organization\",\"name\":\"Tafalgie Therapeutics\",\"url\":\"https:\/\/tafalgie.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png\",\"contentUrl\":\"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png\",\"width\":1024,\"height\":286,\"caption\":\"Tafalgie Therapeutics\"},\"image\":{\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56\",\"name\":\"Tafalgie_client_23\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955\",\"url\":\"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955\",\"contentUrl\":\"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955\",\"caption\":\"Tafalgie_client_23\"},\"sameAs\":[\"http:\/\/tafalgie.fr\"],\"url\":\"https:\/\/tafalgie.fr\/fr\/author\/tafalgie_client_23\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Participation au programme \"IPOready 2024\" - Tafalgie Therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/","og_locale":"fr_FR","og_type":"article","og_title":"Participation au programme \"IPOready 2024\" - Tafalgie Therapeutics","og_description":"Tafalgie Therapeutics participera au programme pre-IPO \u2018IPOready\u2019 2024 organis\u00e9 par Euronext pour la 9\u00e8me ann\u00e9e cons\u00e9cutive Tafalgie Therapeutics, une soci\u00e9t\u00e9 de recherche biopharmaceutique sp\u00e9cialis\u00e9e dans la recherche et l\u2019innovation des traitements pour la pr\u00e9vention et le soulagement des douleurs aigu\u00ebs et chroniques (inflammatoires, postop\u00e9ratoires, neuropathiques) sans effets ind\u00e9sirables, est fi\u00e8re d\u2019annoncer qu\u2019elle a \u00e9t\u00e9 s\u00e9lectionn\u00e9e [&hellip;]","og_url":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/","og_site_name":"Tafalgie Therapeutics","article_published_time":"2024-03-15T14:51:05+00:00","article_modified_time":"2024-07-11T12:27:29+00:00","og_image":[{"url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg","type":"","width":"","height":""}],"author":"Tafalgie_client_23","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Tafalgie_client_23","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#article","isPartOf":{"@id":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/"},"author":{"name":"Tafalgie_client_23","@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56"},"headline":"Participation au programme \u00ab\u00a0IPOready 2024\u00a0\u00bb","datePublished":"2024-03-15T14:51:05+00:00","dateModified":"2024-07-11T12:27:29+00:00","mainEntityOfPage":{"@id":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/"},"wordCount":208,"publisher":{"@id":"https:\/\/tafalgie.fr\/fr\/#organization"},"image":{"@id":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg","keywords":["Euronext","La participation","Pr\u00eat pour l'IPO","Programme","Programme de pr\u00e9-introduction en bourse","Soci\u00e9t\u00e9 europ\u00e9enne"],"articleSection":["Ev\u00e9nements"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/","url":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/","name":"Participation au programme \"IPOready 2024\" - Tafalgie Therapeutics","isPartOf":{"@id":"https:\/\/tafalgie.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#primaryimage"},"image":{"@id":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg","datePublished":"2024-03-15T14:51:05+00:00","dateModified":"2024-07-11T12:27:29+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/tafalgie.fr\/fr\/participer-au-programme-ipoready-2024\/#primaryimage","url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg","contentUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/03\/AdobeStock_261523510-1024x683.jpeg"},{"@type":"WebSite","@id":"https:\/\/tafalgie.fr\/fr\/#website","url":"https:\/\/tafalgie.fr\/fr\/","name":"Tafalgie Therapeutics","description":"","publisher":{"@id":"https:\/\/tafalgie.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tafalgie.fr\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/tafalgie.fr\/fr\/#organization","name":"Tafalgie Therapeutics","url":"https:\/\/tafalgie.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png","contentUrl":"https:\/\/tafalgie.fr\/wp-content\/uploads\/2024\/01\/logo-tafalgie-HD-02-1024x286-1.png","width":1024,"height":286,"caption":"Tafalgie Therapeutics"},"image":{"@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/tafalgie.fr\/fr\/#\/schema\/person\/00336a1fe4b9683bda250c48cef99f56","name":"Tafalgie_client_23","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955","url":"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955","contentUrl":"https:\/\/tafalgie.fr\/wp-content\/litespeed\/avatar\/73a9bf8b8560e1a98575f7d834f9d291.jpg?ver=1777915955","caption":"Tafalgie_client_23"},"sameAs":["http:\/\/tafalgie.fr"],"url":"https:\/\/tafalgie.fr\/fr\/author\/tafalgie_client_23\/"}]}},"_links":{"self":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts\/2111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/comments?post=2111"}],"version-history":[{"count":6,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts\/2111\/revisions"}],"predecessor-version":[{"id":2582,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/posts\/2111\/revisions\/2582"}],"wp:attachment":[{"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/media?parent=2111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/categories?post=2111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tafalgie.fr\/fr\/wp-json\/wp\/v2\/tags?post=2111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}